Content about Symptoms

March 23, 2011

Most patients that suffer from gastroesophageal reflux disease or persistent heartburn symptoms rarely speak with a healthcare provider about their condition, according to a new study conducted on behalf of the American Gastroenterological Association, in partnership with drug maker Takeda.

BETHESDA, Md. — Most patients that suffer from gastroesophageal reflux disease or persistent heartburn symptoms rarely speak with a healthcare provider about their condition, according to a new study conducted on behalf of the American Gastroenterological Association, in partnership with drug maker Takeda.

March 9, 2011

You can expect to see quite a bit of co-promotional activity between PediaCare and Little Remedies in the 2011-2012 cough-cold season, Prestige Brands president and CEO Matthew Mannelly told investors Wednesday morning at the Bank of America Merrill Lynch 2011 Consumer Conference held here.

NEW YORK — You can expect to see quite a bit of co-promotional activity between PediaCare and Little Remedies in the 2011-2012 cough-cold season, Prestige Brands president and CEO Matthew Mannelly told investors Wednesday morning at the Bank of America Merrill Lynch 2011 Consumer Conference held here.

March 4, 2011

NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.

March 4, 2011

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight Nasal Breathe Aid — a snore-relieving product entry into the nasal strip category that retails for a suggested $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each SleepRight Breathe Aid lasts up to 15 days. 

February 23, 2011

Honey Naturals last week started offering parents a free bottle of Zarbee’s children’s cough syrup in exchange for a Facebook photo of them discarding a competitive brand of cough syrup.

SANDY, Utah — Honey Naturals last week started offering parents a free bottle of Zarbee’s children’s cough syrup in exchange for a Facebook photo of them discarding a competitive brand of cough syrup.

February 23, 2011

Splintek Health Products recently launched its SleepRight nasal breathe aide — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight nasal breathe aid — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each breathe aid is reusable and lasts up to 15 days.

February 18, 2011

NEW YORK — The second half of the 2010-2011 cough-cold-flu season actually may realize greater sales of symptom relievers than last year, judging from the four weeks ended Dec. 26. According to Matrixx president and CEO Bill Hemelt, sales of remedies were on the rise in those four weeks. Hemelt noted that the total cough-cold category was 5% higher than the same period last year and growing. 


January 28, 2011

Spouses of older patients with diabetes tend to experience distress if the diabetic patient has symptoms of depression, according to a new study.

WEST LAFAYETTE, Ind. — Spouses of older patients with diabetes tend to experience distress if the diabetic patient has symptoms of depression, according to a new study.

December 17, 2010

Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

IRVINGTON, N.Y. — Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

“The company expects to quickly and smoothly integrate Dramamine into the Prestige portfolio and drive growth through enhanced brand support,” stated Matthew Mannelly, Prestige Brands CEO.

December 7, 2010

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


December 1, 2010

For the week ended Nov. 20, influenza activity increased slightly across the Southeast while remaining relatively low throughout the rest of the country, the Centers for Disease Control and Prevention reported Tuesday.

ATLANTA — For the week ended Nov. 20, influenza activity increased slightly across the Southeast while remaining relatively low throughout the rest of the country, the Centers for Disease Control and Prevention reported Tuesday.

A total of 11 states reported no influenza activity for the period, the CDC reported.

September 19, 2010

Abbott on Monday announced the introduction of EAS Peak, a sports nutrition performance beverage that...

ABBOTT PARK, Ill. Abbott on Monday announced the introduction of EAS Peak, a sports nutrition performance beverage that contains the company’s P3 technology, formulations that help sustain energy, increase workout capacity and protect muscles from breakdown. The P3 technology is a proprietary blend of beta-alanine, isomaltulose and HMB (beta-hydroxy-beta-methylbutyrate).

 

August 26, 2010

Topical BioMedics on Thursday announced that its Topricin pain relief and healing cream has been...

RHINEBECK, N.Y. Topical BioMedics on Thursday announced that its Topricin pain relief and healing cream has been awarded a patent as a treatment of pain associated with fibromyalgia. A Food and Drug Administration-regulated topical biomedicine, Topricin was introduced by the company in 1994, the company stated.

 

August 5, 2010

Drug maker Mission Pharmacal has launched a treatment for urinary tract infections....

SAN ANTONIO Drug maker Mission Pharmacal has launched a treatment for urinary tract infections.

 

Mission announced the launch of Uribel (methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue and hyoscyamine sulfave) capsules, used to relieve local discomfort and inflammation associated with lower urinary tract infections, interstitial cystitis, painful bladder syndrome and urinary tract procedures.

 

 

June 29, 2010

Freeman Beauty Labs has reformulated its Vita-K Professional line to now include Matrixyl 3000, a...

May 23, 2010

The Food and Drug Administration has granted special designation to encourage the development of a...

March 30, 2010

XenaCare announced Wednesday that its over-the-counter pain reliever, Cobroxin, will be featured on a segment...

March 22, 2010

Beverage supplier Reed's on Tuesday announced that CVS/pharmacy has agreed to carry the new Reed's...

February 28, 2010

By all accounts, it’s been a very busy first half of the season for cough-cold manufacturers, even though the 52-week comparable period is only showing a 1.9% lift in overall sales across food, drug and mass (minus Walmart) for the period ended Jan. 24, according to Information Resources Inc. data. For the 2009-2010 season, the weekly percentage of outpatient visits for influenza-like illness peaked at the end of October 2009 at 7.7%, the Centers for Disease Control and Prevention reported. That peak was higher than the three previous influenza seasons as reported by the U.S. Outpatient ILI Surveillance Network.

By all accounts, it’s been a very busy first half of the season for cough-cold manufacturers, even though the 52-week comparable period is only showing a 1.9% lift in overall sales across food, drug and mass (minus Walmart) for the period ended Jan. 24, according to Information Resources Inc. data. For the 2009-2010 season, the weekly percentage of outpatient visits for influenza-like illness peaked at the end of October 2009 at 7.7%, the Centers for Disease Control and Prevention reported. That peak was higher than the three previous influenza seasons as reported by the U.S.

January 20, 2010

Healthy Advice Networks, a provider of physician office-based, patient-education programs, earlier this week announced a...

January 7, 2010

For the week ended Jan. 2, there is now only one state reporting widespread activity...

January 3, 2010

A Mayo Clinic research study published in the January issue of The American Journal of...

December 20, 2009

Consumers can be expected to self-identify a cough, and even locate a cough remedy in...

NEW YORK Consumers can be expected to self-identify a cough, and even locate a cough remedy in the nonprescription aisles. But consumers cannot be expected to distinguish between dextromethorphan and guaifenesin necessarily. Both are indicated for cough relief, but work in entirely different ways. For that you need a readily accessible healthcare professional, such as the pharmacist or nurse practitioner.

 

February 24, 2008

Lubriderm, a skin care brand from Johnson & Johnson Consumer Products, has announced the launch...

February 12, 2008

Woodridge Labs has revamped its Vita-K Solution skin care formulas to include the exclusive ProVita-K...